LYDIA GREFFET: Open Payments
NPI 1942722574 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 34 payments from 5 companies in 2025. Trend: 2023 $689 · 2024 $445 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $336 |
| Amgen Inc. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Organon LLC | 1 | $18 |
Products named: VRAYLAR, EVENITY, BREZTRI, UBRELVY, CAPLYTA, NEXPLANON, QULIPTA.
Industry payments across MO — which companies pay providers there.
